<DOC>
	<DOC>NCT00992147</DOC>
	<brief_summary>Autologous cultured adipocytes (ANTG-adip) is produced by well-established techniques including cell harvesting from lipoaspirates, expansion of adipose tissue derived stem cells, and differentiation into pure and immature adipocytes. This was an open-label, dose-escalation study. Patients are given subcutaneous injection of ANTG-adip and followed for 12 weeks according to the clinical trial protocol.</brief_summary>
	<brief_title>Safety and Efficacy of Autologous Cultured Adipocytes in Patient With Depressed Scar</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<criteria>older than 19 years depressed scar less than volume of 5 ml negative for urine betaHCG for women of childbearing age agreement to participate, with signed informedconsent failure to meet inclusion criteria any immunesuppressive drug, corticosteroid or cytotoxic drug within the previous 30 days allergy to bovinederived materials Diagnosis of cancer, AIDS, HBV or HCV. Patient has a lot of hairs or a tattoo on depressed site Insufficient adipose tissue for manufacturing of ANTGadip Patient has depressed scar caused by a malignant tumor Patient whom investigator consider is not suitable in this study</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2009</verification_date>
</DOC>